Maohuoside A

CAS No. 128988-55-6

Maohuoside A( —— )

Catalog No. M23450 CAS No. 128988-55-6

Maohuoside A promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 244 In Stock
5MG 198 In Stock
10MG 294 In Stock
25MG 468 In Stock
50MG 607 In Stock
100MG 830 In Stock
200MG 1097 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Maohuoside A
  • Note
    Research use only, not for human use.
  • Brief Description
    Maohuoside A promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways.
  • Description
    Maohuoside A promotes osteogenesis of rat mesenchymal stem cells via BMP and MAPK signaling pathways.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    p38 MAPK
  • Recptor
    MAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    128988-55-6
  • Formula Weight
    548.5
  • Molecular Formula
    C27H32O12
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C1C(O)=C(C2=CC=C(OC)C=C2)OC3=C(CCC(C)(O)C)C(O[C@H]4[C@@H]([C@H]([C@@H]([C@@H](CO)O4)O)O)O)=CC(O)=C13
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ming C , Li G , Tao K , et al. Maohuoside A Acts in a BMP‐dependent Manner during Osteogenesis[J]. Phytotherapy Research, 2013, 27(8):1179-1184.
molnova catalog
related products
  • SKF-86002

    SKF-86002 is a potent inhibitor of p38 MAPK with IC50 of 0.5-1 uM, inhibits LPS-induced IL-1 and TNF-α production in human monocyte with IC50 of 1 uM.

  • Losmapimod

    Losmapimod (GSK-AHAB, GW856553X, SB856553)?is a selective, potent, orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively.

  • OVA-E1 peptide TFA

    OVA-E1 peptide TFA activates the p38 and JNK cascades similarly in mutant and wild-type thymocytes.